CINECA IRIS Institutional Research Information System

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival.

Breccia M;Luciano L;Latagliata R;Castagnetti F;FERRERO, Dario;Cavazzini F;Trawinska MM;Annunziata M;Stagno F;Tiribelli M;Binotto G;Crisà E;Musto P;Gozzini A;Cavalli L;Montefusco E;Iurlo A;Russo S;Cedrone M;Rossi AR;Pregno P;Endri M;Spadea A;Molica M;Giglio G;Celesti F;Sorà F;Storti S;D'Addosio A;Cambrin GR;Isidori A;Sica S;Abruzzese E;Speccha G;Rosti G;Alimena G.

2014-01-01